Morgan Stanley’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.39M | Sell |
466,456
-105,578
| -18% | -$946K | ﹤0.01% | 4322 |
|
|
2026
Q1 | $4.66M | Sell |
572,034
-3,145,950
| -85% | -$28.5M | ﹤0.01% | 4188 |
|
|
2025
Q4 | $25M | Buy |
3,717,984
+2,641,540
| +245% | +$19.9M | ﹤0.01% | 2723 |
|
|
2025
Q3 | $9.33M | Sell |
1,076,444
-162,342
| -13% | -$1.26M | ﹤0.01% | 3608 |
|
|
2025
Q2 | $7.8M | Sell |
1,238,786
-739,154
| -37% | -$4.89M | ﹤0.01% | 3681 |
|
|
2025
Q1 | $12.7M | Sell |
1,977,940
-2,962,175
| -60% | -$24.5M | ﹤0.01% | 3125 |
|
|
2024
Q4 | $39.7M | Buy |
4,940,115
+3,387,896
| +218% | +$32.7M | ﹤0.01% | 2051 |
|
|
2024
Q3 | $19.6M | Sell |
1,552,219
-150,516
| -9% | -$1.94M | ﹤0.01% | 2827 |
|
|
2024
Q2 | $21.6M | Sell |
1,702,735
-167,595
| -9% | -$1.69M | ﹤0.01% | 2579 |
|
|
2024
Q1 | $8.94M | Sell |
1,870,330
-5,371,125
| -74% | -$24.9M | ﹤0.01% | 3435 |
|
|
2023
Q4 | $34.8M | Buy |
7,241,455
+4,966,324
| +218% | +$30.4M | ﹤0.01% | 2097 |
|
|
2023
Q3 | $16.5M | Buy |
2,275,131
+194,694
| +9% | +$1.56M | ﹤0.01% | 2659 |
|
|
2023
Q2 | $15.5M | Sell |
2,080,437
-373,402
| -15% | -$2.94M | ﹤0.01% | 2738 |
|
|
2023
Q1 | $17M | Buy |
2,453,839
+674,445
| +38% | +$6.21M | ﹤0.01% | 2596 |
|
|
2022
Q4 | $18.3M | Buy |
1,779,394
+685,214
| +63% | +$12.1M | ﹤0.01% | 2433 |
|
|
2022
Q3 | $19.9M | Sell |
1,094,180
-192,009
| -15% | -$8.32M | ﹤0.01% | 2199 |
|
|
2022
Q2 | $66.1M | Buy |
1,286,189
+383,415
| +42% | +$19.9M | 0.01% | 1192 |
|
|
2022
Q1 | $66.5M | Sell |
902,774
-53,718
| -6% | -$4.79M | 0.01% | 1108 |
|
|
2021
Q4 | $137M | Buy |
956,492
+270,868
| +40% | +$46.5M | 0.02% | 711 |
|
|
2021
Q3 | $142M | Buy |
685,624
+215,448
| +46% | +$47.5M | 0.02% | 656 |
|
|
2021
Q2 | $99.8M | Buy |
470,176
+183,024
| +64% | +$33.5M | 0.01% | 844 |
|
|
2021
Q1 | $52.1M | Sell |
287,152
-61,431
| -18% | -$12.2M | 0.01% | 1147 |
|
|
2020
Q4 | $38.9M | Sell |
348,583
-115,415
| -25% | -$12.3M | 0.01% | 1284 |
|
|
2020
Q3 | $50.3M | Buy |
463,998
+215,103
| +86% | +$26.2M | 0.01% | 896 |
|
|
2020
Q2 | $20.7M | Sell |
248,895
-187,576
| -43% | -$7.17M | ﹤0.01% | 1372 |
|
|
2020
Q1 | $5.93M | Buy |
436,471
+307,875
| +239% | +$2.61M | ﹤0.01% | 2288 |
|
|
2019
Q4 | $511K | Sell |
128,596
-365,083
| -74% | -$1.58M | ﹤0.01% | 4913 |
|
|
2019
Q3 | $2.48M | Sell |
493,679
-160,288
| -25% | -$877K | ﹤0.01% | 3588 |
|
|
2019
Q2 | $3.83M | Buy |
653,967
+388,987
| +147% | +$3.06M | ﹤0.01% | 3203 |
|
|
2019
Q1 | $2.92M | Buy |
264,980
+64,036
| +32% | +$2.02M | ﹤0.01% | 3249 |
|
|
2018
Q4 | $7.39M | Buy |
200,944
+26,923
| +15% | +$1.04M | ﹤0.01% | 2453 |
|
|
2018
Q3 | $6.54M | Sell |
174,021
-139,613
| -45% | -$3.93M | ﹤0.01% | 2893 |
|
|
2018
Q2 | $8.41M | Buy |
313,634
+179,833
| +134% | +$6.08M | ﹤0.01% | 2560 |
|
|
2018
Q1 | $5.62M | Sell |
133,801
-10,743
| -7% | -$432K | ﹤0.01% | 2902 |
|
|
2017
Q4 | $3.58M | Sell |
144,544
-9,003
| -6% | -$220K | ﹤0.01% | 3464 |
|
|
2017
Q3 | $3.5M | Buy |
153,547
+799
| +0.5% | +$17.9K | ﹤0.01% | 3336 |
|
|
2017
Q2 | $3.51M | Sell |
152,748
-4,601
| -3% | -$90.3K | ﹤0.01% | 3259 |
|
|
2017
Q1 | $4.03M | Sell |
157,349
-10,647
| -6% | -$293K | ﹤0.01% | 3090 |
|
|
2016
Q4 | $4.23M | Buy |
167,996
+21,723
| +15% | +$634K | ﹤0.01% | 3171 |
|
|
2016
Q3 | $6.09M | Buy |
146,273
+8,495
| +6% | +$1.1M | ﹤0.01% | 2485 |
|
|
2016
Q2 | $20M | Sell |
137,778
-31,875
| -19% | -$3.65M | 0.01% | 1426 |
|
|
2016
Q1 | $17.5M | Buy |
169,653
+112,735
| +198% | +$12.1M | 0.01% | 1403 |
|
|
2015
Q4 | $9.55M | Sell |
56,918
-8,249
| -13% | -$1.27M | ﹤0.01% | 2026 |
|
|
2015
Q3 | $9.21M | Sell |
65,167
-6,919
| -10% | -$1.55M | ﹤0.01% | 2028 |
|
|
2015
Q2 | $16.1M | Sell |
72,086
-5,941
| -8% | -$1.04M | 0.01% | 1689 |
|
|
2015
Q1 | $12.9M | Buy |
78,027
+8,993
| +13% | +$1.46M | ﹤0.01% | 1809 |
|
|
2014
Q4 | $8.19M | Sell |
69,034
-1,045
| -1% | -$109K | ﹤0.01% | 2255 |
|
|
2014
Q3 | $5.84M | Buy |
70,079
+2,081
| +3% | +$188K | ﹤0.01% | 2509 |
|
|
2014
Q2 | $6.28M | Buy |
67,998
+43,734
| +180% | +$3.84M | ﹤0.01% | 2462 |
|
|
2014
Q1 | $2.2M | Buy |
24,264
+5,771
| +31% | +$645K | ﹤0.01% | 3337 |
|
|
2013
Q4 | $1.89M | Sell |
18,493
-22,807
| -55% | -$1.61M | ﹤0.01% | 3412 |
|
|
2013
Q3 | $2.6M | Buy |
41,300
+34,341
| +493% | +$1.93M | ﹤0.01% | 3011 |
|
|
2013
Q2 | $285K | Buy |
+6,959
| New | +$302K | ﹤0.01% | 4629 |
|
Other funds holding NVAX
SCM
S
Morgan Stanley's NVAX Position: Q2 2026 in Review
Morgan Stanley reduced its Novavax (NVAX) stake by 18% in Q2 2026, selling an estimated $946K and leaving 466,456 shares worth $4.39M. The position accounts for ﹤0.01% of the portfolio, ranked #4322.
Morgan Stanley first reported a position in NVAX in Q2 2013 and has held it in 53 quarters since. The position peaked at $142M in Q3 2021. 265 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Morgan Stanley held 466,456 shares of Novavax worth $4.39M as of Q2 2026.
- Morgan Stanley sold 105,578 Novavax shares in Q2 2026, an estimated $946K.
- Novavax made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4322 holding.
- Morgan Stanley first reported a position in Novavax in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Novavax position peaked at $142M in Q3 2021.
- 265 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.